Figure 1From: Biological efficacy of low versus medium dose aspirin after coronary surgery: results from a randomized trial [NCT00262275]Trial flow diagram. Footnote: numbers that were analyzed were more than expected, taking into account patients who discontinued or did not receive allocated medication owing to intention-to-treat analysis.Back to article page